1. Home
  2. SSTK vs ZVRA Comparison

SSTK vs ZVRA Comparison

Compare SSTK & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

N/A

Current Price

$2.20

Market Cap

570.9M

Sector

Technology

ML Signal

N/A

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

N/A

Current Price

$8.75

Market Cap

664.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSTK
ZVRA
Founded
2003
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
570.9M
664.7M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
SSTK
ZVRA
Price
$2.20
$8.75
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $23.00
AVG Volume (30 Days)
901.5K
★ 997.2K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
★ 44.49%
N/A
EPS Growth
23.76
★ 159.21
EPS
N/A
★ 1.03
Revenue
N/A
★ $106,470,000.00
Revenue This Year
N/A
$43.81
Revenue Next Year
N/A
$15.30
P/E Ratio
★ N/A
$8.83
Revenue Growth
N/A
★ 350.91
52 Week Low
$2.20
$8.01
52 Week High
$21.68
$15.04

Technical Indicators

Market Signals
Indicator
SSTK
ZVRA
Relative Strength Index (RSI) 24.82 35.83
Support Level N/A N/A
Resistance Level $4.67 $9.24
Average True Range (ATR) 0.33 0.66
MACD -0.08 -0.22
Stochastic Oscillator 1.24 0.86

Price Performance

Historical Comparison
SSTK
ZVRA

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: